Articles by Amy Ritter - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Amy Ritter
« Previous
123456789101112
Next »

FDA Introduces New Safety Measures for Opioid Medications

Jul 11, 2012
By: Amy Ritter

On July 9, 2012, FDA approved a risk evaluation and mitigation strategy for extended-release and long-acting opioid medications.

GSK Agrees to $3 Billion Settlement with Justice Department

Jul 3, 2012
By: Amy Ritter

GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve criminal and civil liability resulting from unlawful promotion of certain drugs, failure to report safety data, and alleged false price reporting practices.

35th Anniversary Special: Nanoformulations

A look back at key nanoformulation advances and what lies ahead for nanoparticle-based drug-delivery systems.
Jul 2, 2012
By: Amy Ritter

A look back at key nanoformulation advances and what lies ahead for nanoparticle-based drug-delivery systems.

35th Anniversary Special: Advances in Protein Expression

Improvements in expression platforms and enhanced tools for selecting clones are among the advances of the past few decades.
Jul 2, 2012
By: Amy Ritter

Improvements in expression platforms and enhanced tools for selecting clones are among the advances of the past few decades.

US Supreme Court Upholds Individual Mandate for Health Insurance

Jun 28, 2012
By: Amy Ritter

In a 5-4 ruling, the US Supreme Court upheld the provision of the Affordable Care Act requiring all adults to purchase health insurance or pay a penalty—the so-called individual mandate.

Roche to Close US R&D Site

Jun 27, 2012
By: Amy Ritter

Roche announced that it will be closing its R&D site in Nutley, New Jersey, eliminating approximately 1000 positions.

Eli Lilly Expands Manufacturing Base in China

Jun 13, 2012
By: Amy Ritter

Eli Lilly announced an increase in its manufacturing network in China through an expanded collaboration with Novast Laboratories, a generic and specialty pharmaceutical company based in Nantong, China.

Takeda Completes Acquisition of URL Pharma

Jun 6, 2012
By: Amy Ritter

Takeda Pharmaceuticals announced that it has completed the acquisition of URL Pharma for an upfront payment of $800 million.

Looking for Fingerprints: Bioanalytical Characterization of Biosimilars

Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.
Jun 2, 2012
By: Amy Ritter

Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here